Nature's Sunshine Products, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US6390271012
USD
23.73
-0.26 (-1.08%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
480.14
454.36
445.32
421.91
444.08
385.20
362.21
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
480.14
454.36
445.32
421.91
444.08
385.20
362.21
Raw Material Cost
146.26
143.90
136.01
133.18
126.63
112.02
93.94
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.10
0.15
0.07
0.25
0.25
0.10
0.04
Selling and Distribution Expenses
307.24
288.67
283.26
270.98
280.97
249.40
247.65
Other Expenses
0.18
0.16
0.15
0.13
0.11
0.14
0.21
Total Expenditure (Excl Depreciation)
455.40
434.27
420.87
405.65
409.00
362.91
343.69
Operating Profit (PBDIT) excl Other Income
24.700000000000003
20.099999999999998
24.4
16.299999999999997
35.099999999999994
22.3
18.5
Other Income
5.17
-1.52
1.52
-0.79
-2.60
1.44
-0.44
Operating Profit (PBDIT)
43.75
32.79
37.79
31.15
49.01
39.21
34.08
Interest
0.10
0.15
0.07
0.25
0.25
0.10
0.04
Exceptional Items
0.00
0.00
-5.70
0.00
-0.42
-0.81
-2.40
Gross Profit (PBDT)
333.88
310.47
309.31
288.74
317.45
273.19
268.27
Depreciation
13.84
14.22
11.82
15.68
16.52
15.48
15.99
Profit Before Tax
29.81
18.43
20.20
15.21
31.82
22.82
15.64
Tax
9.36
10.53
3.79
14.66
1.61
-0.14
8.71
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
19.52
7.70
15.08
-0.39
28.85
21.34
6.76
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
19.52
7.70
15.08
-0.39
28.85
21.34
6.76
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.93
0.20
1.34
0.94
1.35
1.62
0.16
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
20.45
7.89
16.42
0.55
30.21
22.96
6.93
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
161.55
155.31
154.06
142.91
158.20
155.39
129.21
Earnings per share (EPS)
1.06
0.4
0.77
-0.02
1.42
1.07
0.34
Diluted Earnings per share
1.06
0.4
0.77
-0.02
1.42
1.07
0.34
Operating Profit Margin (Excl OI)
5.15%
4.42%
5.49%
3.85%
7.9%
5.79%
5.11%
Gross Profit Margin
9.09%
7.18%
7.19%
7.32%
10.88%
9.94%
8.73%
PAT Margin
4.07%
1.69%
3.39%
-0.09%
6.5%
5.54%
1.87%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 5.66% vs 2.04% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 159.49% vs -51.83% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 12.54% vs -5.51% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Nature's Sunshine Products, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
480.14
925.26
-445.12
-48.11%
Other Operating Income
0.00
0.00
0.00
Total Operating income
480.14
925.26
-445.12
-48.11%
Raw Material Cost
146.26
233.41
-87.15
-37.34%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.10
0.84
-0.74
-88.10%
Selling and Distribution Expenses
307.24
630.29
-323.05
-51.25%
Other Expenses
0.18
0.99
-0.81
-81.82%
Total Expenditure (Excl Depreciation)
455.40
874.39
-418.99
-47.92%
Operating Profit (PBDIT) excl Other Income
24.74
50.86
-26.12
-51.36%
Other Income
5.17
4.94
0.23
4.66%
Operating Profit (PBDIT)
43.75
95.50
-51.75
-54.19%
Interest
0.10
0.84
-0.74
-88.10%
Exceptional Items
0.00
-13.43
13.43
100.00%
Gross Profit (PBDT)
333.88
691.84
-357.96
-51.74%
Depreciation
13.84
39.70
-25.86
-65.14%
Profit Before Tax
29.81
41.53
-11.72
-28.22%
Tax
9.36
30.05
-20.69
-68.85%
Provisions and contingencies
0
0
0.00
Profit After Tax
19.52
10.76
8.76
81.41%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
19.52
10.76
8.76
81.41%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.93
0.72
0.21
29.17%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
20.45
11.48
8.97
78.14%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
161.55
533.10
-371.55
-69.70%
Earnings per share (EPS)
1.06
0.58
0.48
82.76%
Diluted Earnings per share
1.06
0.58
0.48
82.76%
Operating Profit Margin (Excl OI)
5.15%
5.50%
0.00
-0.35%
Gross Profit Margin
9.09%
8.78%
0.00
0.31%
PAT Margin
4.07%
1.16%
0.00
2.91%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 48.01 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 5.66% vs 2.04% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 2.05 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 159.49% vs -51.83% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.86 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 12.54% vs -5.51% in Dec 2024

Annual - Interest
Interest 0.01 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 5.15%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024